The rise and fall of Theranos, in one graphic
May 15, 2016, 01:32 IST
Theranos, the blood-testing startup with a $9 billion valuation, has had a turbulent year.
Advertisement
On Wednesday, the company announced major changes, including that its president and chief operating officer Sunny Balwani, who served as CEO and founder Elizabeth Holmes' second-in-command, is retiring.
Here's a review of the events that led up to this point over the last year.
Complimentary Tech Event
Transform talent with learning that works
Capability development is critical for businesses who want to push the envelope of innovation.Discover how business leaders are strategizing around building talent capabilities and empowering employee transformation.Know More
.jp2)